Cohort of Hospitalized Patients Suspected of Leptospirosis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

200 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-01-06

Study Completion Date

2027-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

COLEPT is a prospective interventional study that intends to better inform about leptospirosis, a neglected zoonotic infectious disease. During prospective follow-up of hospitalized acute leptospirosis cases, the participants will be assessed during 1 year for epidemiological, clinical, bacteriological and immunological data. Main intervention consists in blood sampling and biological bank constitution.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Study of the Innate Immune Response to the Acute Phase of Human Leptospirosis - IMMUNOLEPTO

NCT05413720

Leptospirosis

COMPLETED NA

Immune Response After Leptospirosis Infection

NCT02898519

Leptospirosis

UNKNOWN

Study of Decreasing Kinetics of the Leptospiremia During Antibiotic Treatment of Leptospirosis in Martinique

NCT02000635

Leptospirosis

UNKNOWN

Characterizing the Host Response to Leptospirosis for Better Diagnosis and Prognosis - NIHFI

NCT06945822

Leptospirosis

NOT_YET_RECRUITING NA

Analysis of Cerebrospinal Fluid in Patients With Cerebral Toxoplasmosis at CHSD (2004-2024)

NCT07044037

Toxoplasmosis, Cerebral Toxoplasmosis Meningitis +3 more

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Leptospirosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

hospitalized patients diagnosed with leptospirosis

hospitalized patients diagnosed with leptospirosis: 12 months of follow up with biological samples and data collection

Group Type EXPERIMENTAL

Blood and urine sampling and blood banking

Intervention Type OTHER

In routine management, blood and urine will be sampled for each patients and specific analyses carried out. Only blood samples will be banked.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Blood and urine sampling and blood banking

In routine management, blood and urine will be sampled for each patients and specific analyses carried out. Only blood samples will be banked.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* clinico-biological manifestations compatible with acute leptospirosis OR proven leptospirosis with serological testing or PCR
* onset of symptoms within 21 days
* participant benefits of health insurance

Exclusion Criteria

* participant's refusal, or refusal from his relatives in case of major incapacity of the eligible participant precluding expression of his will (coma, stay in intensive care unit))

Minimum Eligible Age

1 Day

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes